Skip to content

Clinical Intervention Application of Digital Therapeutics: Cognitive Function Training Software

Clinical Intervention Application of Digital Therapeutics: Cognitive Function Training Software

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600116628
Enrollment
Unknown
Registered
2026-01-13
Start date
2026-01-13
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild cognitive impairment (MCI) caused by stroke, traumatic brain injury, and other etiologies

Interventions

Control Group:Routine Rehabilitation Alone
Experimental Group:Routine Rehabilitation + Digital Therapy of Cognitive Function Training Software

Sponsors

The Seventh Affiliated Hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18–80 years; 2.Mild cognitive impairment caused by stroke, craniocerebral injury, etc. 3.Possess the ability to use basic smart devices (mobile phones/tablets), or family members can assist in completing the training; 4.Voluntarily sign the informed consent form and promise to cooperate in completing the 2-week intervention and follow-up;

Exclusion criteria

Exclusion criteria: 1.Patients with a clear diagnosis of severe dementia who are unable to cooperate with the training; 2.In the acute phase of delirium (such as post-operative, infection-related) or with uncontrolled epileptic seizures (with a history of seizures within the past 3 months); 3.Severe visual and auditory impairments (such as blindness, deafness) and inability to complete training with the help of assistive devices (such as glasses, hearing aids); 4.Obvious mental symptoms are unstable (such as acute severe depression with self-harm thoughts, acute phase of schizophrenia), and it is necessary to first refer to a psychiatric specialist for treatment. 5.organ failure of the heart, liver, kidney, etc. (such as NYHA cardiac function class IV, decompensated cirrhosis); 6.Participated in other cognitive intervention clinical studies within the past 3 months; 7.Those who refuse to sign the informed consent form or cannot guarantee follow-up visits;

Design outcomes

Primary

MeasureTime frame
Cognitive function;

Secondary

MeasureTime frame
Security;Daily functions;compliance;Quality of life;

Countries

China

Contacts

Public ContactDongfeng Huang

The Seventh Affiliated Hospital, Sun Yat-sen University

huangdf_sysu@163.com+86 755 81206511

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026